Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to study the combination regimen of satraplatin and paclitaxel in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Agennix
• Treatments: Albumin-Bound Paclitaxel; Paclitaxel; Satraplatin

Criteria

Inclusion Criteria:

• Histologically confirmed advanced NSCLC

• Patients must not have received any prior antineoplastic chemotherapy or investigational product for lung cancer prior to study entry.

• Patients must have at least one unidimensionally measurable lesion definable by magnetic resonance imaging (MRI) or computed tomography (CT) scan.

• ECOG performance status of ≤ 2.